1. American Thoracic Society. Chronic bronchitis, asthma and pulmonary emphysema: a statement by the Committee on Diagnostic Standarts for Nontuberculos Respiratory Diseases. Am Rev Respir Dis 1962;85:762-8.

2. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies (statement). Am Rev Respir Dis 1991;144:1201-18.

3. ATS Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:77-120.

4. Barnes P. New therapies for chronic obstructive pulmonary disease. Thorax 1998;53:137-47.

5. Buist AS. Health education needs arising from the development of guidelines in chronic obstructive pulmonary disease. In Barnes PJ, Buist AS (eds): The Role of Anticholinergices in Chroniç Obstructive Pulmonary Disease and Chronic Asthma. Cheshire: Gardiner-Caldwell Communications Limited, United Kingdom. 1997:160-71.

6. Bliman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest 1998;113:883-9.

7. Brenner M, et al: Lung volume reduction surgery for emphysema. Chest 1996;110:205-218.

8. BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52:1-26.

9. Burrows B, et al. Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 1986;133:794-80.

10. Cazzola M, Matera MG. Should long-acting b2-agonists be considered an alternative first choice option for the treatment of stable COPD. Respiratory Medicine 1999; 93:227-9.

11. Celli BR. Standards for the optimal management of COPD. Chest 1998; 113:283-7.

12. Chanez P, Vignole AM, Bousquet J. Remodelling of the airways in chronic obstructive pulmonary disease. Eur Respir Rev 1997;7:142-5.

13. Cooper J, et al: Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996;112:1319-30.

14. Cooper J, Patterson G. Lung volume surgery for severe emphysema. Chest Surg Clin North Am 1995;5:815-31.

15. Corris PA, Higenbottan T, Goltstrow P. Surgical treatment for diffuse emphysema. European Respiratory Monograph 1998;7:288-96.

16. Curtis JR, et al. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994;49:162-70.

17. Çelikel T, Sungur M, Ceyhan B, Karakurt S. Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratiory failure. Chest 1998;114:;1636-42.

18. Davies RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;140:82-9.

19. Deslauriers J. A perspective on the role of surgery in chronic obstructive lung disease. Chest Surg Clin North Am 1995;5:757-62.

20. Dosman JA, Cockroft DW (ed). Obstructive Lung Disease, Part I, Chronic Obstructive Pulmonary Disease. The Med Clin North Am 1996;80.

21. Dureil B. Risk of anesthesia in respiratory diseases. Presse Med 1991; 26:1223-9.

22. Erk M, Umut S, Mirici A, Yılmaz V, et al. The knowledge of chest physicians about the diagnosis and management of COPD in Turkey. Eur Respir J 1997;10: 379.

23. Fletcher C, Peto R. The natural history of chronic air flow obstruction. Brit Med J 1997;1:1645-8.

24. Hosenpud JD, et al: The Registry of International Society for Heart and Lung Transplantation: Thirteenth Official Report 1996. J Heart Lung Transplant 1996;15:655-74.

25. Jackson CV. Preoperative pulmonary evaluation. Arc Intern Med 1988;148:2120-7.

26. Jeffrey P. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998; 53:129-36.

27. Jeffry PK. Pathology of asthma and COPD: a synopsis. Eur Respir Rev 1997;43:111-8.

28. Jones PW, et al. A self-complete measure of health status for chronic airflow limitation. The St. George`s Respiratory Questionnarie. Am Rev Respir Dis 1992;145:1321-7.

29. Knudson R, Stander JR, Kaltenborn WT, et al. Expiratory computed tomography for assessment of suspected pulmonary emphysema. Chest 1991;99:1357-66.

30. Kocabaş A, Kara K, Özgür G, et al. Value of preoperative spirometry to predict postoperative pulmonary complications. Respir Med 1996;90:25-30.

31. Lefrak SS, Selection for LVRS: Multi-Center patient selection criteria. Washington University School of Medicine 1995.

32. Medical Research Council Working Party: Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale, chronic bronchitis and emphsema. Lancet 1981;1:681-6.

33. Moğulkoç N, Karakurt S, Isalska B, et al. Acute purulant exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med 1999;160:349-53.

34. Morgan M, Singh S. Practical Pulmonary Rehabilitation. Chapman-Hall Medical, London, UK. 1997, 1st ed.

35. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstuctive pulmonary disease: C clinical trial. Ann Intern Med 1980; 93:391-8.

36. Patlerson G. Indications unilateral, bilateral, heart lung and lobar transplant proceedings. Clin Chest Med 1997;18:225-30.

37. Postma DS, Siafakas NM. Management of Chronic Obstructive Lung Disease, European Society Monograph 7,1998.

38. Pulmonary Rehabilitation. Join ACCP/AACVPR Evidence-Based Gui-delines. Chest 1997;112:1363-96.

39. Rennard S. Pathophsyological mechanisms of COPD. Eur Respir Rev 1997; 7:206-10.

40. Roue C, et al: Lung volume reduction in patients with severe diffuse emphysema. Chest 1996;110:28-34.

41. Sanders C. The radiographic diagnosis of emphysema. Radiol Clin North Am 1991;29:1019-30.

42. Seatta M. Central airways inflammation in the development of COPD. Eur Respir Rev 1997;7:109-10.

43. Senior RM, Anthonisen R. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1998;157:139-47.

44. Shah SS, Goldstrow P. Surgical treatment of bullous emphysema: experience with the Brompton technique. Ann Thorac Surg 1994;58:1452-6.

45. Siafakas NM, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). ERS-Consensus Statement. Eur Respir J 1995;8:1398-420.

46. Snider GL, Kleinerman J, Thurlbeck WM, Bengali ZK. The definition of emphysema: report of a National Heart, Lung and Blood Institute, Division of Lung Diseases, Workshop. Am Rev Respir Dis 1985;132:182-85.

47. Société de Pneumologie de Langue Française. Recommandations pour la Prise en Charge des Bronchopneumopathies Chroniques Obstructives. Rev Mal Resp 1997;14:7-91.

48. Stanescu DC, Rodenstein DO, Hoeven C, Robert A. “Sensitive tests” are poor predictors of the decline in forced expiratory volume in one second in middle aged smokers. Am Rev Respir Dis 1987;135:585-90.

49. Stockley RA. Cellular mechanisms in the pathogenesis of COPD. Eur Respir Rev 1996;6:264-9.

50. Strategies in preserving lung health and preventing COPD and associated diseases: The National Lung Health Education Program (NLHEP). Chest 1998;113:139.

51. T.C. Sağlık Bakanlığı Araştırma, Planlama ve Koordinasyon Kurulu Başkanlığı. Hastalık İstatistikleri. 1964-1994.

52. The Nebuliser Project Group of the British Thoracic Society Standards of Care Committee. Current best practice for nebuliser treatment. Thorax 1997,52:49-52.

53. Tiep BL. Disease management of COPD with pulmonary rehabilitation. Chest 1997;112:1630-56.

54. Travaline JM, Addonizio VP, Criner GJ. Effect of bullectomy on diaphragm strength. Am J Respir Crit Care Med 1995;152:1697-701.

55. Umut S, Tutluoğlu B, Tosun GA and KOAH Çalışma Grubu: Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. J Chemotherapy 1999;11:211-4.

56. Zuege DJ, Whitelaw WA. Management of acute respiratory failure in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 1997;3:190-7.